PUBLICATIONS · 26195720
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2015 Nov 10
- First author
- Kim YH
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2015 Nov 10;33(32):3691-6. doi: 10.1200/JCO.2015.61.9486.
- note
- Source null
- related pmid
- 26392103
- relationship
- Comment in
Authors and identifiers
- name
- Kim YH
- type
- Author
- name
- Tavallaee M
- type
- Author
- name
- Sundram U
- type
- Author
- name
- Salva KA
- type
- Author
- name
- Wood GS
- type
- Author
- name
- Li S
- type
- Author
- name
- Rozati S
- type
- Author
- name
- Nagpal S
- type
- Author
- name
- Krathen M
- type
- Author
- name
- Reddy S
- type
- Author
- name
- Hoppe RT
- type
- Author
- name
- Nguyen-Lin A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kim YH
- type
- Author
- name
- Tavallaee M
- type
- Author
- name
- Sundram U
- type
- Author
- name
- Salva KA
- type
- Author
- name
- Wood GS
- type
- Author
- name
- Li S
- type
- Author
- name
- Rozati S
- type
- Author
- name
- Nagpal S
- type
- Author
- name
- Krathen M
- type
- Author
- name
- Reddy S
- type
- Author
- name
- Hoppe RT
- type
- Author
- name
- Nguyen-Lin A
- type
- Author
- bibliography ids
- nci-bib-355fde2028b524e875e9c5f5
- book metadata
- content sha256
- d270def7135b8984a21367815839e2d2613bdec01392e99f7a2198510c4a5fba
- document type
- citation
- dois
- 10.1200/JCO.2014.60.3969
- electronic publication date
- display
- 2015 Jul 20
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26195720
- immutable id
- pubmed:26195720@d270def7135b8984a21367815839e2d2613bdec01392e99f7a2198510c4a5fba
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 32
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3750-8
- volume
- 33
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2015 Nov 10;33(32):3691-6. doi: 10.1200/JCO.2015.61.9486.
- note
- Source null
- related pmid
- 26392103
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 26195720
- provenance
- batch id
- 4c1ece5bfc3d8e2be622
- provider
- NCBI PubMed ESummary
- record sha256
- 4e7142ce026445cd3cf3215dbce305fadd872d76d9ab00e768eff13753e45343
- response sha256
- 85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
- retrieved at
- 2026-09-09T23:47:12.730551+00:00
- publication date
- display
- 2015 Nov 10
- precision
- day
- year
- 2015
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.
Preserved source evidence · Not medical advice
Triangle